AddLife AB
OTC:ADDLF
Relative Value
The Relative Value of one ADDLF stock under the Base Case scenario is 118.75 USD. Compared to the current market price of 42 USD, AddLife AB is Undervalued by 65%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
ADDLF Competitors Multiples
AddLife AB Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
SE |
AddLife AB
OTC:ADDLF
|
12.4B USD | 1.3 | 65.4 | 9.5 | 22.4 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 36.9 | 22.8 | 33.4 | ||
US |
Danaher Corp
NYSE:DHR
|
184B USD | 4.2 | 22.8 | 16.6 | 20.4 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.5B CHF | 5.6 | 57.3 | 19.7 | 28.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.9B USD | 6.1 | 33.1 | 26.4 | 31.8 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
40.5B USD | 2.7 | 29.9 | 16.3 | 25.2 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.9B USD | 7.1 | 34.2 | 23.9 | 26.5 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.6B USD | 9.1 | 46.9 | 32.5 | 39.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.6B USD | 3.1 | 37.4 | 16.9 | 26 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |